These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35538274)

  • 1. The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis.
    Goh CXY; Tan YK; Tan CH; Leow AST; Ho JSY; Tan NHW; Goh S; Ho AFW; Sharma VK; Chan BPL; Yeo LLL; Tan BYQ
    J Thromb Thrombolysis; 2022 Jul; 54(1):183-190. PubMed ID: 35538274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patients.
    Andreis A; Imazio M; Piroli F; Avondo S; Casula M; Paneva E; De Ferrari GM
    Eur J Prev Cardiol; 2022 Feb; 28(17):1916-1925. PubMed ID: 33779702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
    Kofler T; Kurmann R; Lehnick D; Cioffi GM; Chandran S; Attinger-Toller A; Toggweiler S; Kobza R; Moccetti F; Cuculi F; Jolly SS; Bossard M
    J Am Heart Assoc; 2021 Aug; 10(16):e021198. PubMed ID: 34369166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials.
    Xu H; Mao L; Liu H; Lin Z; Zhang Y; Yang J
    Heart Lung Circ; 2022 May; 31(5):685-695. PubMed ID: 35033433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine for Patients With Coronary Artery Disease: A Systematic Review and Meta-analysis.
    Shrestha DB; Budhathoki P; Sedhai Y; Khadka M; Pokharel S; Yadav S; Patel T; Elgendy I; Mir WAY; Patel NK
    J Cardiovasc Pharmacol; 2022 Apr; 79(4):420-430. PubMed ID: 34935703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials.
    Chen Y; Zhang H; Chen Y; Li M; Luo W; Liu Y; Fu Y; Xia H; Xu C; Jiang Y; Wu Y
    Clin Rheumatol; 2022 Jun; 41(6):1873-1887. PubMed ID: 35138464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine in Stable Coronary Artery Disease.
    Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
    Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colchicine for cardiovascular medicine: a systematic review and meta-analysis.
    Casula M; Andreis A; Avondo S; Vaira MP; Imazio M
    Future Cardiol; 2022 Aug; 18(8):647-659. PubMed ID: 35787150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis.
    Katsanos AH; Palaiodimou L; Price C; Giannopoulos S; Lemmens R; Kosmidou M; Georgakis MK; Weimar C; Kelly PJ; Tsivgoulis G
    Eur J Neurol; 2020 Jun; 27(6):1035-1038. PubMed ID: 32134555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
    Fiolet ATL; Opstal TSJ; Mosterd A; Eikelboom JW; Jolly SS; Keech AC; Kelly P; Tong DC; Layland J; Nidorf SM; Thompson PL; Budgeon C; Tijssen JGP; Cornel JH
    Eur Heart J; 2021 Jul; 42(28):2765-2775. PubMed ID: 33769515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease.
    Xia M; Yang X; Qian C
    Am J Cardiol; 2021 Feb; 140():33-38. PubMed ID: 33137319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
    Bytyçi I; Bajraktari G; Penson PE; Henein MY; Banach M; ;
    Br J Clin Pharmacol; 2022 Feb; 88(4):1520-1528. PubMed ID: 34409634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Colchicine on Cardiovascular Outcomes in Patients with Coronary Artery Disease: A Systematic Review and One-Stage and Two-Stage Meta-Analysis of Randomized-Controlled Trials.
    Teo YN; Teo YH; Syn NL; Goh MW; Yoong CSY; Lee CH; Chan MY; Chai P; Yeo TC; Sia CH
    High Blood Press Cardiovasc Prev; 2021 Jul; 28(4):343-354. PubMed ID: 34003455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine therapy in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials.
    Al-Abdouh A; Barbarawi M; Khan SU; Osman M; Upadhrasta S; Solipuram V; Abusnina W; Radaideh Q; Zhao D; Michos ED
    Coron Artery Dis; 2021 Aug; 32(5):441-447. PubMed ID: 32732517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Colchicine in the Treatment of Patients With Coronary Artery Disease: A Mini-Review.
    Yong J; Tian J; Jiang W; Zhao X; Zhang H; Song X
    Clin Ther; 2022 Aug; 44(8):1150-1159. PubMed ID: 35907660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine in Patients with Chronic Coronary Disease.
    Nidorf SM; Fiolet ATL; Mosterd A; Eikelboom JW; Schut A; Opstal TSJ; The SHK; Xu XF; Ireland MA; Lenderink T; Latchem D; Hoogslag P; Jerzewski A; Nierop P; Whelan A; Hendriks R; Swart H; Schaap J; Kuijper AFM; van Hessen MWJ; Saklani P; Tan I; Thompson AG; Morton A; Judkins C; Bax WA; Dirksen M; Alings M; Hankey GJ; Budgeon CA; Tijssen JGP; Cornel JH; Thompson PL;
    N Engl J Med; 2020 Nov; 383(19):1838-1847. PubMed ID: 32865380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Different Dosing Regimens of Colchicine in Patients With Coronary Artery Disease: A Network Meta-analysis of 15 Randomized Controlled Trials.
    Wang S; Mu Y; Tan L; Hao J
    J Cardiovasc Pharmacol; 2023 Jul; 82(1):13-22. PubMed ID: 37026756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.
    Nidorf SM; Fiolet ATL; Eikelboom JW; Schut A; Opstal TSJ; Bax WA; Budgeon CA; Tijssen JGP; Mosterd A; Cornel JH; Thompson PL;
    Am Heart J; 2019 Dec; 218():46-56. PubMed ID: 31706144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial.
    Akrami M; Izadpanah P; Bazrafshan M; Hatamipour U; Nouraein N; Drissi HB; Manafi A
    BMC Cardiovasc Disord; 2021 Dec; 21(1):583. PubMed ID: 34876021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.